Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study.
about
Standardization of cytokine flow cytometry assaysImpact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOTDerivation of induced pluripotent stem cells from human peripheral blood T lymphocytesVACUTAINER CPT and Ficoll density gradient separation perform equivalently in maintaining the quality and function of PBMC from HIV seropositive blood samples.Standardization and performance evaluation of mononuclear cell cytokine secretion assays in a multicenter studyPlasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients.Cytokine gene expression occurs more rapidly in stimulated peripheral blood mononuclear cells from human immunodeficiency virus-infected persons.The Center for HIV/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cells.Circulating angiogenic cells can be derived from cryopreserved peripheral blood mononuclear cellsEvaluation of peripheral blood mononuclear cell processing and analysis for Survival Motor Neuron protein.Effects of blood transportation on human peripheral mononuclear cell yield, phenotype and function: implications for immune cell biobanking.Substantial improvements in performance indicators achieved in a peripheral blood mononuclear cell cryopreservation quality assurance program using single donor samples.Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061.Quality assurance program for peripheral blood mononuclear cell cryopreservation.A Comparative Study of SMN Protein and mRNA in Blood and Fibroblasts in Patients with Spinal Muscular Atrophy and Healthy ControlsLongitudinal assessment of de novo T cell production in relation to HIV-associated T cell homeostasis failureValue of a quality assessment program in optimizing cryopreservation of peripheral blood mononuclear cells in a multicenter study.Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization.Defining T-cell-mediated immune responses in rotavirus-infected juvenile rhesus macaques.Standardized Serum-Free Cryomedia Maintain Peripheral Blood Mononuclear Cell Viability, Recovery, and Antigen-Specific T-Cell Response Compared to Fetal Calf Serum-Based MediumEffect of cryopreservation of peripheral blood mononuclear cells (PBMCs) on the variability of an antigen-specific memory B cell ELISpot.Viability and functional activity of cryopreserved mononuclear cells.Brain-derived circulating endothelial cells in peripheral blood of newborn infants with seizures: a potential biomarker for cerebrovascular injury.Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus.Toward Optimal Cryopreservation and Storage for Achievement of High Cell Recovery and Maintenance of Cell Viability and T Cell Functionality.Viability and Functionality of Cryopreserved Peripheral Blood Mononuclear Cells in Pediatric Dengue.Kinetics of human myeloid-derived suppressor cells after blood draw.Controlled-rate freezer cryopreservation of highly concentrated peripheral blood mononuclear cells results in higher cell yields and superior autologous T-cell stimulation for dendritic cell-based immunotherapy.Viable mononuclear cell stability study for implementation in a proficiency testing program: impact of shipment conditions.Establishing acceptance criteria for cell-mediated-immunity assays using frozen peripheral blood mononuclear cells stored under optimal and suboptimal conditions.Distinct T-helper cell responses to Staphylococcus aureus bacteremia reflect immunologic comorbidities and correlate with mortality.
P2860
Q24811983-3F970E6C-036D-4021-9C2B-A27CD1827C1DQ24815388-04FECC63-22B4-4E69-BCB3-DD6A94286A8DQ28750802-6B516741-561F-4B17-B054-8A6FCC622CD9Q33244711-92B45379-BB94-4260-A54F-C7A646EE44DBQ33265973-B78E1473-6430-4899-A0F5-C19558ECFC90Q33608661-EFC02690-21F6-41F6-BD5E-9874F054DC57Q33998597-446FAE0F-EDE7-41A3-BF97-8F47375C6FABQ34067001-70FE22C3-D95C-4CCA-BF25-16A91896255AQ34469305-67C195FF-17C0-4210-9716-4961E4E9ED1AQ34505876-55179DD4-4EBE-458D-9130-E766BCA8873BQ34776611-678ADC9F-54A3-4288-AA21-2FE45C7E1B50Q35635848-BC195C14-37A3-41F5-9007-0C6E0A444E3BQ35673834-C952C76C-66FB-42FB-A542-364D40803F04Q36095112-5B96C641-64AD-46CC-9D0C-E6477CCC1D60Q36205773-C3940036-123F-4513-B886-18F9B4E871B7Q36628405-A4602C01-897C-4C16-A544-E8AC155B6202Q36757861-11EBD06C-0AF1-4A4A-A4D8-E99D96D35058Q37301872-D2E83D99-B019-4300-8807-61F9E07492E9Q37511547-81307ED5-378C-414F-8B7F-ECF1DE3DA392Q38544409-329229E5-EC76-4C31-BED6-D185D4F7002FQ39094135-18162758-A651-4527-8A23-07650D6DCED7Q39507446-943D23DB-E54D-41B5-88F2-D528845BF5EAQ39508467-7CC2CBEA-3E22-4E29-B292-40EBACCCA1DAQ39508564-BB1617F3-2230-4843-8EB6-9C797B0C3AE9Q39736321-B3FCAFFB-A5B9-4A1D-B6F6-BFA8A2C171E1Q40114619-A8261BCF-4281-4127-A278-2B376B8FC66CQ40142945-04218E29-2B77-45D5-A7C6-9D5794E5EFA1Q41325461-5D3FA2D8-C489-42A4-B06A-7B6A07946691Q42409561-0E892FC2-6605-4561-977D-C4FD18DBEA83Q42800541-579A908E-A2D8-496B-8E92-81D538416CC1Q52563129-E7A646EB-4967-42F6-816F-D505CA511525
P2860
Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Viability and recovery of peri ...... years in a multicenter study.
@ast
Viability and recovery of peri ...... years in a multicenter study.
@en
type
label
Viability and recovery of peri ...... years in a multicenter study.
@ast
Viability and recovery of peri ...... years in a multicenter study.
@en
prefLabel
Viability and recovery of peri ...... years in a multicenter study.
@ast
Viability and recovery of peri ...... years in a multicenter study.
@en
P2093
P2860
P1476
Viability and recovery of peri ...... 2 years in a multicenter study
@en
P2093
C A Kleeberger
C R Rinaldo
J B Margolick
J V Giorgi
P2860
P577
1999-01-01T00:00:00Z